相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice
Jerome Robert et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice
Nicholas F. Fitz et al.
BRAIN (2015)
In vitro discrimination of the role of LRP1 at the BBB cellular level: Focus on brain capillary endothelial cells and brain pericytes
Pietra Candela et al.
BRAIN RESEARCH (2015)
ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?
Takahisa Kanekiyo et al.
NEURON (2014)
Differences in amyloid-β clearance across mouse and human blood-brain barrier models: Kinetic analysis and mechanistic modeling
Hisham Qosa et al.
NEUROPHARMACOLOGY (2014)
Intravenously Injected Human Apolipoprotein A-I Rapidly Enters the Central Nervous System via the Choroid Plexus
Sophie Stukas et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Oxysterols decrease apical-to-basolateral transport of Aβ peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells
Julien Saint-Pol et al.
BRAIN RESEARCH (2013)
Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
Fabien Gosselet et al.
CURRENT ALZHEIMER RESEARCH (2013)
A Multifaceted Role for apoE in the Clearance of Beta-Amyloid across the Blood-Brain Barrier
Corbin Bachmeier et al.
NEURODEGENERATIVE DISEASES (2013)
The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease
Ayman ElAli et al.
FRONTIERS IN PHYSIOLOGY (2013)
Clusterin in neurological disorders: Molecular perspectives and clinical relevance
Yves Charnay et al.
BRAIN RESEARCH BULLETIN (2012)
Structural Basis for Increased Toxicity of Pathological Aβ42:Aβ40 Ratios in Alzheimer Disease
Kris Pauwels et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Plasma Clusterin and the Risk of Alzheimer Disease
Elisabeth M. C. Schrijvers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrier
Corbin Bachmeier et al.
CYTOTECHNOLOGY (2010)
Apical-to-Basolateral Transport of Amyloid-beta Peptides through Blood-Brain Barrier Cells is Mediated by the Receptor for Advanced Glycation End-Products and is Restricted by P-Glycoprotein
Pietra Candela et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice
Iliya Lefterov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
Terry L. Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Amyloid Efflux Transporter Expression at the Blood-Brain Barrier Declines in Normal Aging
Gerald D. Silverberg et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer's Disease
Anika M. S. Hartz et al.
MOLECULAR PHARMACOLOGY (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease
Robert D. Bell et al.
ACTA NEUROPATHOLOGICA (2009)
Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: Use of an in vitro model
Fabien Gosselet et al.
BRAIN RESEARCH (2009)
Human apolipoprotein A-I binds amyloid-β and prevents Aβ-induced neurotoxicity
Andrea C. Paula-Lima et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2009)
Evidence for Altered LRP/RAGE Expression in Alzheimer Lesion Pathogenesis
Brian Jeynes et al.
CURRENT ALZHEIMER RESEARCH (2008)
apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening
Maxime Culot et al.
TOXICOLOGY IN VITRO (2008)
Cerebral clearance of human amyloid-β peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes
Shingo Ito et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The relation between apolipoprotein A-I and dementia - The Honolulu-Asia aging study
Jane S. Saczynski et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Distinct early folding and aggregation properties of Alzheimer amyloid-β peptides Aβ40 and Aβ42 -: Stable trimer or tetramer formation by Aβ42
Yun-Ru Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
IgG-assisted age-dependent clearance of Alzheimer's amyloid β peptide by the blood-brain barrier neonatal Fc receptor
R Deane et al.
JOURNAL OF NEUROSCIENCE (2005)
Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms
J Attems
ACTA NEUROPATHOLOGICA (2005)
Mouse syngenic in vitro blood-brain barrier model:: a new tool to examine inflammatory events in cerebral endothelium
C Coisne et al.
LABORATORY INVESTIGATION (2005)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Antiinflammatory properties of HDL
PJ Barter et al.
CIRCULATION RESEARCH (2004)
Clearing amyloid through the blood-brain barrier
BV Zlokovic
JOURNAL OF NEUROCHEMISTRY (2004)
Uptake and transport of high-density lipoprotein (HDL) and HDL-associated α-tocopherol by an in vitro blood-brain barrier model
Z Balazs et al.
JOURNAL OF NEUROCHEMISTRY (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Cholesterol metabolism in the brain
JM Dietschy et al.
CURRENT OPINION IN LIPIDOLOGY (2001)
Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits Aβ aggregation and toxicity
RP Koldamova et al.
BIOCHEMISTRY (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease
A Merched et al.
NEUROBIOLOGY OF AGING (2000)
分享论文
